Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 27 October, 2015 by The TZ Newswire Staff

Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update

Isis Pharmaceuticals announces plans to provide details regarding its late-stage pipeline, and also extends its gains following yesterday’s development milestone.

See also
- Next Article PBOC sets yuan reference rate for today at 6.3536
- Previous Article Why Pacira Pharmaceuticals Soared Nearly 20% Today
Editorial Calender

October 2015

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30 31

« Sep Nov »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 27 October, 2015 by The TZ Newswire Staff

Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update

See also

Editorial Calender

Recent Tags